Drug Shortage Report for IMITREX
Report ID | 125052 |
Drug Identification Number | 02212188 |
Brand name | IMITREX |
Common or Proper name | Sumatriptan succinate injection |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 6MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2x0.5mL (Refill pack/L’emballage de recharge) |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-24 |
Estimated end date | 2020-10-08 |
Actual end date | 2020-09-30 |
Shortage status | Resolved |
Updated date | 2020-10-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-10-08 | French | Compare |
v3 | 2020-10-08 | English | Compare |
v2 | 2020-09-25 | French | Compare |
v1 | 2020-09-25 | English | Compare |
Showing 1 to 4 of 4